Abstract:Objective:To summarize the incidence, prognosis and risk factors of perioperative diarrhea in renal transplantation, and to provide strategies and basis for the prevention or treatment of perioperative diarrhea in renal transplantation recipients.Methods:The clinical data of 360 renal transplant recipients in the First Affiliated Hospital, Zhejiang University School of Medicine were analyzed retrospectively. The recipients were divided into diarrhea group (n=146) and the non-diarrhea group (n=214) according to whether perioperative diarrhea occurred. The clinical characteristics of the diarrhea group and the non-diarrhea group were compared, and the effects of recipient age, sex, transplantation type, immune induction regimen, CNI and mycophenolic acid (MPA) types, infection prevention regimen, and delayed graft function (DGF) occurrence on the incidence of diarrhea were analyzed. Measurement data with normal distribution were compared by group t test. Enumeration data were compared by the χ2 test. Factors with P<0.10 in univariate analysis were included in multivariate logistic regression analysis. A P<0.05 was considered statistically significant.Results:The incidence of perioperative diarrhea was 40.6% (146/360). The occurrence time of diarrhea was (6±3) d (1-20 d), the frequency of diarrhea was (3.7±1.2) times/d (3-10 times/d), and the median duration of diarrhea was 1.5 d (1-18 d). All patients were relieved after symptomatic treatment. The hospital stays of diarrhea group and non-diarrhea group were (22±15) d and (12±7) d, respectively, and the difference had a statistical significance (t=6.732, P<0.05). Serum creatinine was (144±80) and (118±42) μmol/L in diarrhea and non-diarrhea recipients at discharge, respectively, and the difference was not statistically significant (t=1.968, P>0.05). The results of univariate analysis showed that there were significant differences in recipient age, donor kidney type, immunization induction regimen, infection prevention regimen and DGF occurrence between the diarrhea and non-diarrhea groups (all P<0.05), and there was no significant difference in sex, CNI and MPA types (all P>0.05). The results of Logistic multivariate analysis showed that the occurrence of DGF after transplantation (OR=4.647, 95% confidence interval: 1.948-11.088) and the use of different infection prevention regimens after transplantation were independent risk factors for perioperative diarrhea in renal transplant recipients. Compared with cefuroxime, recipients who used piperacillin/tazobactam (OR=5.749, 95% confidence interval: 1.455-22.713) were more likely to lead to perioperative diarrhea.Conclusions:The incidence of perioperative diarrhea in renal transplant recipients is high, which can lead to prolonged hospital stay. DGF after transplantation and the use of specific infection prevention regimen are independent risk factors.

Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation

Incidence and risk factors for perioperative diarrhea in renal transplant recipients

Presentation, anagement, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study

Chronic Norovirus Infections in Cardiac Transplant Patients

Norovirus Management and Outcomes in a Multicenter Pediatric Kidney Transplant Population

Norovirus in Transplantation

Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study

Severity and outcome of the norovirus infection in children after intestinal transplantation

Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus

Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine

An outbreak of norovirus infection in a bone marrow transplant unit

Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single‐center retrospective study

PTH-250 Clinical course and management of norovirus infection following small bowel transplantation in children

Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management

Enterovirus Infections in Solid Organ Transplant Recipients: a Clinical Comparison from a Regional University Hospital in the Netherlands

Diagnosis and management of diarrhea in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Approach to patient reported outcome measures selection and implementation in a chronic norovirus clinical efficacy trial for patients after solid organ transplant

927. Clinical Characteristics and Outcomes of Norovirus Infection in Patients with Hematologic Malignancies: A Retrospective, Single Center Study

Reconstitution of norovirus-specific T cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection

The Role Of Chronic Norovirus Infection In The Enteropathy Associated With Common Variable Immunodeficiency

Intrahost Norovirus Evolution in Chronic Infection Over 5 Years of Shedding in a Kidney Transplant Recipient